biblio
“Cocrystallization of multi-kinase inhibitor pazopanib with fenamic acids: improving dissolution and inhibiting cell migration”, CrystEngComm, vol. 25, no. 39, pp. 5565-5574, 2023.
, “Dabrafenib-panobinostat salt: improving the dissolution rate and inhibition of BRAF melanoma cells”, ACS Omega, vol. 8, no. 20, pp. 18255-18265, 2023.
, “The effects of cis and trans butenedioic acid on the physicochemical behavior of lumefantrine”, Crystengcomm, vol. 24, no. 1, pp. 156-168, 2022.
, “Enhanced solubility, permeability, and tabletability of nicorandil by salt and cocrystal formation”, Crystengcomm, vol. 23, no. 1, pp. 227-237, 2021.
, “Generation and evaluation of pharmacologically relevant drug-drug cocrystal for gout therapy”, Crystal Growth & Design, vol. 20, no. 6, pp. 3577-3583, 2020.
, “Improving the dissolution rate of the anticancer drug dabrafenib”, Crystal Growth & Design, vol. 20, no. 2, pp. 1035-1046, 2020.
, “Crystalline acylhydrazone photoswitches with multiple mechanical responses”, Crystal Growth & Design, vol. 19, no. 5, pp. 3039-3044, 2019.
, “Hepatoprotective cocrystals of isoniazid: synthesis, solid state characterization, and hepatotoxicity studies”, Crystal Growth & Design, vol. 19, no. 09, pp. 5161-5172, 2019.
, “High-solubility salts of the multiple sclerosis drug teriflunomide”, Crystal Growth & Design, vol. 19, no. 09, pp. 5407-5417, 2019.
, “Entacapone: improving aqueous solubility, diffusion permeability, and cocrystal stability with theophylline”, Crystal Growth & Design, vol. 18, no. 10, pp. 6061-6069, 2018.
, “Salts and salt cocrystals of the antibacterial drug pefloxacin”, Crystal Growth & Design, vol. 18, no. 5, pp. 2824-2835, 2018.
, “Polymorphism, isostructurality and physicochemical properties of glibenclamide salts”, CrystEngComm, vol. 19, no. 6, pp. 918-929, 2017.
, “Crystal engineering of a zwitterionic drug to neutral cocrystals: a general solution for floxacins”, Chemical Communications, vol. 52, no. 85, pp. 12610-12613, 2016.
,